Outset Medical, Inc.: Business Overview, Financials & Competitive Analysis
Outset Medical, Inc. scores 5/10 on the AskCyborg Cyborg Score (Mixed). Early-stage medical device innovator with transformational dialysis technology facing profitability hurdles but supported by recurring revenue potential and market tailwinds. Outset operates in a high-growth medical technology sector with innovative products and strategic partnerships. However, the company faces near-term profitability challenges with recent revenue decline and significant operating losses.
What is Outset Medical, Inc.'s industry? Outset Medical, Inc. (outsetmedical.com) operates in Medical Device Manufacturing / Nephrology / Dialysis Technology. AskCyborg classifies Outset Medical, Inc. under Medical Device Manufacturing / Nephrology / Dialysis Technology in its company registry.
Outset Medical is a medical technology company that develops the Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilit...
Cyborg Score thesis
Early-stage medical device innovator with transformational dialysis technology facing profitability hurdles but supported by...
Read the full analyst-debate transcript →Get the Latest Outset Medical, Inc. Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report FreeOutset Medical, Inc. Overview
Pro stress-test →Outset Medical is a medical technology company that develops the Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities. The company operates in the critical nephrology market, addressing a significant clinical need for improved dialysis solutions.
Strategic Profile
Pro stress-test →The company is positioned for faster recurring revenue growth through rapid Tablo adoption and strategic partnerships, with demographic trends and expanding home care markets offering lasting tailwinds for long-term profitability. The business model leverages recurring revenue streams and strong customer retention.
Competitive Landscape
Pro stress-test →Outset competes in the hemodialysis and kidney care market against established medical device manufacturers and healthcare providers. Primary competitive advantages stem from Tablo's innovative integrated design, software capabilities, and recurring consumables model. The company targets both acute care and home dialysis settings, differentiating from traditional stationary dialysis equipment.
Industry Context
Outset Medical, Inc. operates in Medical Device Manufacturing / Nephrology / Dialysis Technology.
Key facts
Founded: 2003 · Headquarters: San Jose, US · Employees: 560 · Revenue: $113.69M (2024) · Market cap: $67-330M